1. Home
  2. CTM vs CLNN Comparison

CTM vs CLNN Comparison

Compare CTM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTM

Castellum Inc.

N/A

Current Price

$0.61

Market Cap

63.1M

Sector

Technology

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

N/A

Current Price

$3.88

Market Cap

57.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTM
CLNN
Founded
2019
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
57.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
CTM
CLNN
Price
$0.61
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$33.75
AVG Volume (30 Days)
581.5K
105.9K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
83.33
N/A
EPS
N/A
N/A
Revenue
$52,866,001.00
$200,000.00
Revenue This Year
$20.36
$17.64
Revenue Next Year
$6.37
$19,516.77
P/E Ratio
N/A
N/A
Revenue Growth
18.10
N/A
52 Week Low
$0.48
$3.48
52 Week High
$1.36
$13.50

Technical Indicators

Market Signals
Indicator
CTM
CLNN
Relative Strength Index (RSI) 45.72 45.97
Support Level $0.57 $3.92
Resistance Level $0.65 $4.70
Average True Range (ATR) 0.03 0.39
MACD 0.00 -0.00
Stochastic Oscillator 52.18 49.61

Price Performance

Historical Comparison
CTM
CLNN

About CTM Castellum Inc.

Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: